EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Relationship Between Serum Levels of Thyroglobulin Antibody and the Risk of Recurrence in Patients With Differentiated Thyroid Cancer

Amirian Fatemeh, Yaghoubi Mohammad Ali, Mehrad-Majd Hassan iD, Mohebbi Masoud, Layegh Parvin, Vazifeh-Mostaan Leila, Dadgar Moghaddam Maliheh, Amirian Zahra iD, Taghavi Ghazaleh iD

Cancer Reports · 2025

DOI: 10.1002/cnr2.70191 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Reports, 2025. Verfasst von Amirian Fatemeh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Department of Internal Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Autoantibodies, Neoplasm Recurrence, Local, Thyroglobulin. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mashhad University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Thyroid Autoantibodies (TgAbs) are associated with autoimmune thyroid disorders and are also used in thyroid cancer follow‐up to monitor for recurrence of disease. This study aimed to explore the potential utility of TgAbs as a surrogate tumor marker and examine the relationship between fluctuations in TgAbs levels and disease recurrence in patients with Differentiated Thyroid Cancer (DTC).

Methods

This cohort study was conducted on a sample of 97 patients who underwent thyroidectomy for differentiated thyroid cancer (DTC) between the years 2017 and 2021. Following surgery (with or without lymph node dissection), levothyroxine therapy and 131 iodine were prescribed (as necessary). Regular laboratory evaluations were conducted, which involved measuring Tg and TgAb at 3 and 6 months postoperatively. Patients were classified based on recurrence rate and different levels of TgAb, and ROC analysis was applied. All data were analyzed with SPSS24, and a p ‐value < 0.05 was considered statistically significant.

Results

For low‐risk patients, TgAb trends over time showed an increase at 6 months, while for high‐risk patients, TgAb levels continuously rose starting from 3 months. Although TgAb levels above the functional sensitivity threshold did not predict recurrence overall, changes in TgAb levels at 6 months compared to 3 months after surgery were indicative of recurrence.

Conclusion

In the entire population, having TgAb levels higher than the functional sensitivity threshold had no risk of various relapses. However, changes in TgAb serum levels at 6 months after surgery, compared to 3 months after surgery, can serve as an indication of tumor recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsAutoantibodiesNeoplasm Recurrence, LocalThyroglobulinHumansMaleFemaleMiddle AgedThyroidectomyAdultBiomarkers, TumorFollow-Up StudiesAgedIodine RadioisotopesRetrospective StudiesYoung Adult

Stichwörter der Autor:innen

Tg Abdifferented thyroid cancerthyroid cancer

Substanzen

AutoantibodiesThyroglobulinanti-thyroglobulinBiomarkers, TumorIodine Radioisotopes

Autor:innen und Institutionen

  • Faculty of Medicine, Department of Internal Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Clinical Research Development Unit, Ghaem Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Endocrine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Endocrinology & Metabolism Member of Metabolic Syndrome Research Center (MSRC), Mashhad University of Medical Sciences, Mashhad, Iran.

ORCID-Profile: Mehrad-Majd Hassan, Amirian Zahra, Taghavi Ghazaleh

Förderung

  • Mashhad University of Medical Sciences

Zitieren

APA

Fatemeh, A., Mohammad Ali, Y., Hassan, M. M., Masoud, M., Parvin, L., Leila, V. M., Maliheh, D. M., Zahra, A., & Ghazaleh, T. (2025). The Relationship Between Serum Levels of Thyroglobulin Antibody and the Risk of Recurrence in Patients With Differentiated Thyroid Cancer. Cancer Reports. https://doi.org/10.1002/cnr2.70191

Vancouver

Fatemeh A, Mohammad Ali Y, Hassan MM, Masoud M, Parvin L, Leila VM, et al. The Relationship Between Serum Levels of Thyroglobulin Antibody and the Risk of Recurrence in Patients With Differentiated Thyroid Cancer. Cancer Reports. 2025. doi:10.1002/cnr2.70191

BibTeX
@article{Fatemeh2025,
  author = {Fatemeh, Amirian and Mohammad Ali, Yaghoubi and Hassan, Mehrad-Majd and Masoud, Mohebbi and Parvin, Layegh and Leila, Vazifeh-Mostaan and Maliheh, Dadgar Moghaddam and Zahra, Amirian and Ghazaleh, Taghavi},
  title = {The Relationship Between Serum Levels of Thyroglobulin Antibody and the Risk of Recurrence in Patients With Differentiated Thyroid Cancer},
  journal = {Cancer Reports},
  year = {2025},
  doi = {10.1002/cnr2.70191}
}
Kostenlos starten →